Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia During Carbapenem Therapy
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00984-16
Full Text
Open PDFAbstract
Available in full text
Date
August 29, 2016
Authors
Publisher
American Society for Microbiology